Unknown PHASE4 INTERVENTIONAL 3-arm NCT04664764

Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.

The Effect of Long- and Intermediate-acting Insulins on Glycemic Control and Risk of Hypoglycemia Among Toddlers and Preschool Children With Newly Onset Type 1 Diabetes Mellitus: A Randomized Three Armed Trial

Sponsor: Ain Shams University

Conditions Type 1 Diabetes Mellitus With Hypoglycemia type1diabetes

Interventions Degludec Glargine NPH insulin

Updated 5 times since 2021 Last updated: Feb 12, 2021 Started: Feb 21, 2019 Primary completion: Feb 28, 2021 Completion: Mar 10, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Type 1 Diabetes Mellitus With Hypoglycemia and type1diabetes, this trial is ongoing. The trial is conducted by Ain Shams University and has accumulated 5 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Mar 2023 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Mar 2021 — Mar 2023 [monthly]

Recruiting PHASE4
Jan 2021 — Mar 2021 [monthly]

Recruiting PHASE4

First recorded

Feb 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ain Shams University

Data source: Ain Shams University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt